(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate(CAS: 64519-44-4)

CAS Number
Related Products
2,3,5,6-Tetramethyl-1,4-benzenediamine
CAS Number: 3102-87-2
1,1-Diphenylmethanamine
CAS Number: 91-00-9
4-fluoro-1,3-dioxolan-2-one
CAS Number: 114435-02-8
3-Hydroxybutanoic acid calcium salt
CAS Number: 586976-56-9
(3-Bromo-2-pyridinyl)methanol
CAS Number: 52378-64-0
Other Suppliers for (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate
Basic Information
Molecular Formula
C15H25NO3
Molecular Weight
267.37 g/mol
Chemical Identifiers
SMILES
O=C([C@H](CC1)NC1=O)O[C@H]2[C@H](C(C)C)CC[C@@H](C)C2
InChIKey
SLHPMAOXNSLXEH-MROQNXINSA-N
Database References
MDL Number
MFCD11114057
FAQ
This compound falls under the regulatory frameworks such as REACH in the EU, which requires manufacturers and importers to register substances if they have a tonnage threshold. Additionally, it must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), which includes specific labeling and safety data sheet requirements. In the US, FDA and EPA regulations also apply for any products containing this compound, particularly concerning its use in pharmaceuticals and environmental exposure limits.
Alternative reagents include (1S,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate, which is a stereoisomer. Other common alternatives include (1R,2S,5S)-2-isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate and (1S,2S,5S)-2-isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate. These compounds can be used as substitutes depending on the specific reaction requirements and desired product stereochemistry.
The market for (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-oxo-L-prolinate is growing, driven by increasing demand in pharmaceutical applications, particularly in the development of prodrugs and novel drug candidates. Research trends focus on its use in the synthesis of more complex bioactive molecules and its potential as a precursor in organic synthesis. Price trends are influenced by supply chain dynamics and demand in the pharmaceutical industry.
Waste containing this compound should be collected in a closed container and handled according to local regulations. It is advisable to incinerate the waste in an appropriately licensed facility, as it may contain hazardous components. Environmental protection measures include ensuring that waste does not enter waterways and that appropriate personal protective equipment is used during handling. Disposal should only be performed by professionals with the necessary training and certifications to ensure safe and compliant disposal.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Min Huiping
3771156959@qq.com
















